{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:13:19Z","timestamp":1791411199764,"version":"4.3.3"},"reference-count":73,"publisher":"Japanese Society for the Study of Xenobiotics","issue":"3","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2006]]},"DOI":"10.2133\/dmpk.21.173","type":"journal-article","created":{"date-parts":[[2006,7,21]],"date-time":"2006-07-21T02:41:18Z","timestamp":1153449678000},"page":"173-185","source":"Crossref","is-referenced-by-count":333,"title":["Human Carboxylesterase Isozymes: Catalytic Properties and Rational Drug Design"],"prefix":"10.2133","volume":"21","author":[{"given":"Teruko","family":"Imai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"900","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"2) Bodor, N. and Buchwald, P.: Designing safer (soft) drugs by avoiding the formation of toxic and oxidative metabolites. Methods Mol. Biol.<\/i>, 186<\/b>:, 301-312 (2002).","DOI":"10.1385\/1-59259-173-6:301"},{"key":"2","doi-asserted-by":"crossref","unstructured":"3) Rooseboom, M., Commandeur, J. N. and Vermeulen, N. P.: Enzyme-catalyzed activation of anticancer prodrugs. Pharmacol. Rev.<\/i>, 56<\/b>: 53-102 (2004).","DOI":"10.1124\/pr.56.1.3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"4) Imai, T., Yoshigae, Y., Hosokawa, M., Chiba, K. and Oragiri, M.: Evidence for the involvement of a pulmonary first-pass effect via carboxylesterase in the disposition of a propranolol ester derivative after intravenous administration. J. Pharmacol. Exp. Ther.<\/i>, 307<\/b>: 1234-1242 (2003).","DOI":"10.1124\/jpet.103.056499"},{"key":"4","doi-asserted-by":"crossref","unstructured":"5) Yoshigae, Y., Imai, T., Aso, T and Otagiri, M.: Species differences in the disposition of propranolol prodrugs derived from hydrolase activity in intestinal mucosa. Life Sci.<\/i>, 62<\/b>: 1231-1241 (1998).","DOI":"10.1016\/S0024-3205(98)00053-8"},{"key":"5","doi-asserted-by":"crossref","unstructured":"6) Ahmed, S., Imai, T. and Otagiri, M.: Evaluation of stereoselective transdermal transport and concurrent cutaneous hydrolysis of several ester prodrugs of propranolol: mechanism of stereoselective permeation. Pharm. Res.<\/i>, 13<\/b>: 1524-1529 (1996).","DOI":"10.1023\/A:1016031629845"},{"key":"6","doi-asserted-by":"crossref","unstructured":"7) Takai, S., Matsuda, A., Usami, Y., Adachi, T., Sugiyama, T., Katagiri, Y., Tatematsu, M. and Hirano, K.: Hydrolytic profile for ester- or amide-linkage by carboxylesterases pI 5.3 and 4.5 from human liver. Biol. Pharm. Bull.<\/i>, 20<\/b>: 869-873 (1997).","DOI":"10.1248\/bpb.20.869"},{"key":"7","unstructured":"8) Humerickhouse, R., Lohrbach, K., Li, L., Bosron, W. F. and Dolan, M. E.: Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2. Cancer. Res.<\/i>, 60<\/b>: 1189-1192 (2000)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"9) Tabata, T., Katoh, M., Tokudome, S., Nakajima, M. and Yokoi, T.: Identification of the cytosolic carboxylesterase catalyzing the 5′-deoxy-5-fluorocytidine formation from capecitabine in human liver. Drug Metab. Dispos.<\/i>, 32<\/b>: 1103-1110 (2004).","DOI":"10.1124\/dmd.104.000554"},{"key":"9","doi-asserted-by":"crossref","unstructured":"10) Pindel, E. V., Kedishvili, N. Y., Abraham T. L., Brzezinski M. R., Zhang J., Dean R. A. and Bosron W. F.: Purification and cloning of a broad substrate specificity human liver carboxylesterase that catalyzes the hydrolysis of cocaine and heroin. J. Biol. Chem.<\/i>, 272<\/b>: 14769-14775 (1997).","DOI":"10.1074\/jbc.272.23.14769"},{"key":"10","doi-asserted-by":"crossref","unstructured":"11) Zhang J., Burnell J. C., Dumaual N. and Bosron W. F.: Binding and hydrolysis of meperidine by human liver carboxylesterase hCE-1. J. Pharmacol. Exp. Ther.<\/i>, 290<\/b>: 314-318 (1999).","DOI":"10.1016\/S0022-3565(24)34901-8"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12) Satoh. T. and Hosokawa. M.: The mammalian carboxylesterases: from molecules to functions. Annu. Rev. Pharmacol. Toxicol.<\/i>, 38<\/b>: 257-288 (1998).","DOI":"10.1146\/annurev.pharmtox.38.1.257"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13) Satoh. T., Taylor. P., Bosron. W. F., Sanghani. P., Hosokawa. M. and Du. B. N.: Current progress on esterases: from molecular structure to function. Drug Metab. Dispos.<\/i>, 30<\/b>: 488-493 (2002).","DOI":"10.1124\/dmd.30.5.488"},{"key":"13","doi-asserted-by":"crossref","unstructured":"14) Munger. J. S., Shi. G-P., Mark, E. A., Chin, M. D., Gerard, C. and Chapman, H. A.: A serin esterase released by human alveolar macrophages is closely related to liver microsomal carboxylesterases. J. Biol. Chem.<\/i>, 266<\/b>: 18832-18838 (1991).","DOI":"10.1016\/S0021-9258(18)55139-5"},{"key":"14","unstructured":"15) Xu, G., Zhang, W., Ma, M. K. and McLeod, H. L.: Human carboxylesterase 2 is commonly expressed in tumor tissue and is correlated with activation of irinotecan. Clin. Cancer Res.<\/i>, 8<\/b>: 2605-2611 (2002)."},{"key":"15","unstructured":"16) Schwer, H., Langmann, T., Daig, R., Becker, A., Aslanidis, C. and Schmitz, G.: Molecular cloning and characterization of a novel putative carboxylesterase, present in human intestine and liver. Biochem. Biophys. Res. Commun.<\/i>, 233<\/b>: 117-120 (1997)."},{"key":"16","doi-asserted-by":"crossref","unstructured":"17) Junge, W., Heymann, E and Krisch, K.: Human liver carboxylesterase: purification and molecular properties. Arch. Biochem. Biophys.<\/i>, 165<\/b>: 749-763 (1974).","DOI":"10.1016\/0003-9861(74)90304-X"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18) Inoue, M., Morikawa, M., Tsuboi, M., Ito, Y. and Sugiura, M.: Comparative study of human intestinal and hepatic esterases as related to enzaymatic properties and hydrolyzing activity for ester-type drugs. Jpn. J. Pharmacol.<\/i>, 30<\/b>: 529-535 (1980).","DOI":"10.1254\/jjp.30.529"},{"key":"18","doi-asserted-by":"publisher","unstructured":"19) Mori, M., Hosokawa, M., Ogasawara, Y., Tsukada, E. and Chiba, K.: cDNA cloning, characterization and stable expression of novel human brain carboxylesterase. FEBS Letters<\/i>, 458<\/b>: 17-22 (1999).","DOI":"10.1016\/S0014-5793(99)01111-4"},{"key":"19","doi-asserted-by":"crossref","unstructured":"20) Sanghani, S. P., Quinney, S. K., Fredenburg, T. B., Davis, W. I., Murry, D. J. and Bosron, W. F.: Hydrolysis of irinotecan and its oxidative metabolites, 7-ethyl-10-[4-N-(5-aminopentanoic acid)-1-piperidino] carbonyloxycamptothecin and 7-ethyl-10-[4-(1-piperidino)-1-amino]-carbonyloxycamptothecin, by human carboxylesterases CES1A1, CES2, and a newly expressed carboxylesterase isoenzyme, CES3. Drug Metab. Dispos.<\/i>, 32<\/b>: 505-511 (2004).","DOI":"10.1124\/dmd.32.5.505"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21) Quinney, S. K., Sanghani, S. P., Davis, W. I., Hurley, T. D., Sun, Z., Murry, D. J. and Bosron, W. F.: Hydrolysis of capecitabine to 5′-deoxy-5-fluorocytidine by human carboxylesterases and inhibition by loperamide. J. Pharmacol. Exp. Ther.<\/i>, 313<\/b>: 1011-1016 (2005).","DOI":"10.1124\/jpet.104.081265"},{"key":"21","doi-asserted-by":"crossref","unstructured":"22) Guemei, A. A., Cottrell, J., Band, R., Hehman, H., Prudhomme, M., Pavlov, M. V., Grem, J. L., Ismail, A. S., Bowen, D., Taylor, R. S. and Takimoto, C. H.: Human plasma carboxylesterase and butyrylcholinesterase enzyme activity: correlations with SN-38 pharmacokinetics during a prolonged infusion of irinotecan. Cancer Chemother. Pharmacol.<\/i>, 47<\/b>: 283-290 (2001).","DOI":"10.1007\/s002800000258"},{"key":"22","unstructured":"23) Yan, B., Yang, D., Bullock, P. and Parkinson, A.: Rat serum carboxylesterase cloning, expression, regulation, and evidence of secretion from liver. J. Biol. Chem.<\/i>, 270<\/b>: 19128-19134 (1995)."},{"key":"23","doi-asserted-by":"crossref","unstructured":"24) Li, B, Sedlacek, M, Manoharan, I, Boopathy, R, Duysen, E. G., Masson, P., and Lockridge, O.: Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. Biochem. Pharmacol.<\/i>, 70<\/b>: 1673-1684 (2005).","DOI":"10.1016\/j.bcp.2005.09.002"},{"key":"24","doi-asserted-by":"crossref","unstructured":"25) Mentlein, R., Heiland, S and Heymann E.: Simultaneous purification and comparative characterization of six serine hydrolases from rat liver microsomes. Arch. Biochem. Biophys.<\/i>, 200<\/b>: 547-559 (1980).","DOI":"10.1016\/0003-9861(80)90386-0"},{"key":"25","doi-asserted-by":"crossref","unstructured":"26) Mentlein, R., Rix-Matzen, H. and Heymann, E.: Subcellular localization of non-specific carboxylesterases, acylcarnitine hydrolase, monoacylglycerol lipase and palmitoyl-CoA hydrolase in rat liver. Biochim. Biophys. Acta<\/i>, 964<\/b>: 319-328 (1988).","DOI":"10.1016\/0304-4165(88)90032-3"},{"key":"26","doi-asserted-by":"crossref","unstructured":"27) Block, W and Arndt, R.: Chromatographic study on the specificity of bis-p<\/i>-nitrophenylphospate in vivo<\/i>: Identification of labeled proteins of rat liver after intravenous injection of bis-p<\/i>-nitro[14C]phenylphosphate as carboxylesterases and amidases. Biochim. Biophys. Acta<\/i>, 524<\/b>: 85-93 (1978).","DOI":"10.1016\/0005-2744(78)90106-7"},{"key":"27","doi-asserted-by":"crossref","unstructured":"28) Sterri, S. H., Johnsen, B. A. and Fonnum, F.: A radiochemical assay method for carboxylesterase, and comparison of enzyme activity towards the substrates methyl[1-14<\/sup>C]butyrate and 4-nitrophenyl butyrate. Biophem. Pharmacol.<\/i>, 34<\/b>: 2779-2785 (1985).","DOI":"10.1016\/0006-2952(85)90579-9"},{"key":"28","doi-asserted-by":"crossref","unstructured":"29) Heymann, E., Mentlein, R., Schmalz, R., Schwabe, C. and Wagenmann F.: A method for the estimation of esterase synthesis and degradation and its application to evaluate the influence of insulin and glucagons. Eur. J. Biochem.<\/i>, 102<\/b>: 509-519 (1979).","DOI":"10.1111\/j.1432-1033.1979.tb04267.x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"30) Imai, T., Taketani, M., Shii, M., Hosokawa, M. and Chiba, K.: Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in the human liver and small intestine. Drug Metab. Dispos.<\/i>, in press.","DOI":"10.1124\/dmd.106.009381"},{"key":"30","unstructured":"31) Hosokawa, M., Endo, T., Fujisawa, M., Hara, S., Iwata, N., Sato, Y. and Satoh, T.: Interindividual variation in carboxylesterase levels in human liver microsomes. Drug Metab. Dispos.<\/i>, 23<\/b>: 1022-1027 (1995)."},{"key":"31","doi-asserted-by":"crossref","unstructured":"32) Brzezinski, M. R., Abraham, T. L., Stone, C. L., Dean, R. A. and Bosron, W. F.: Purification and characterization of a human liver cocaine carboxylesterase that catalyzes the production of benzoylecgonine and the formation of cocaethylene from alcohol and cocaine. Biochem. Pharmacol.<\/i>, 48<\/b>: 1747-1755 (1994).","DOI":"10.1016\/0006-2952(94)90461-8"},{"key":"32","doi-asserted-by":"publisher","unstructured":"33) Pennings, J. M., Leccese, A. P. and Wolff, F. A.: Effect of concurrent use of alcohol and cocaine. Addiction<\/i>, 97<\/b>: 773-783 (2002).","DOI":"10.1046\/j.1360-0443.2002.00158.x"},{"key":"33","doi-asserted-by":"crossref","unstructured":"34) Bencharit, S, Morton, C. L, Xue, Y, Potter, P. M and Redinbo, M. R. Structural basis of heroin and cocaine metabolism by a promiscuous human drug-processing enzyme. Nat Struct Biol.<\/i>, 10<\/b>: 349-356 (2003).","DOI":"10.1038\/nsb919"},{"key":"34","doi-asserted-by":"crossref","unstructured":"35) Becker, A., Bottcher, A., Lackner, K. J., Fehringer, P., Notka, F., Aslanidis, C. and Schmitz, G.: Purification, cloning, and expression of human enzyme with acyl coenzyme A: cholesterol acyl-transferase activity, which is identical to liver carboxylesterase. Arterioscler Thromb.<\/i>, 14<\/b>: 1346-1355 (1994).","DOI":"10.1161\/01.ATV.14.8.1346"},{"key":"35","doi-asserted-by":"crossref","unstructured":"36) Bora, P. S., Guruge, B. L., Miller, D. D., Chaitman, B. R. and Ruyle, M. S.: Purification and characterization of human heart fatty acid ethyl ester synthase\/carboxylesterase. J. Mol. Cell. Cardiol.<\/i>, 28<\/b>: 2027-2032 (1996).","DOI":"10.1006\/jmcc.1996.0195"},{"key":"36","doi-asserted-by":"crossref","unstructured":"37) Diczfalusy, M. A., Bjorkhem, I., Einarsson, C., Hillebrant, C. G., and Alexson, S. E.: Characterization of enzymes involved in formation of ethyl esters of long-chain fatty acids in humans. J Lipid Res.<\/i>, 42<\/b>: 1025-1032 (2001).","DOI":"10.1016\/S0022-2275(20)31590-X"},{"key":"37","doi-asserted-by":"crossref","unstructured":"38) Bora, P. S., Farrar, M. A., Miller, D. D., Chaitman, B. R. and Guruge B. L.: Myocardial cell damage by fatty acid ethyl esters. J. Cardiovasc. Pharmacol.<\/i>, 27<\/b>: 1-6 (1996).","DOI":"10.1097\/00005344-199601000-00001"},{"key":"38","unstructured":"39) Potter, P. M., Wolverton, J. S., Morton, C. L., Wierdl, M. and Danks M. K.: Cellular localization domains of a rabbit and a human carboxylesterase: influence on irinotecan (CPT-11) metabolism by the rabbit enzyme. Cancer Res.<\/i>, 58<\/b>: 3627-3632 (1998)."},{"key":"39","doi-asserted-by":"publisher","unstructured":"40) Kroetz, D. L., McBride, O. W. and Gonzalez, F. J.: Glycosylation-dependent activity of baculovirus-expressed human liver carboxylesterases: cDNA cloning and characterization of two highly similar enzyme forms. Biochemistry<\/i> 32<\/b>: 11606-11617 (1993)","DOI":"10.1021\/bi00094a018"},{"key":"40","doi-asserted-by":"crossref","unstructured":"41) Bencharit, S, Morton, C. L., Hyatt, J. L., Kuhn, P., Danks, M. K., Potter, P. M. and Redinbo, M. R.: Crystal structure of human carboxylesterase 1 complexed with the alzheimer's drug tacrine: from binding promiscuity to selective inhibition. Chemistry Biol.<\/i>, 10<\/b>: 341-349 (2003)","DOI":"10.1016\/S1074-5521(03)00071-1"},{"key":"41","doi-asserted-by":"crossref","unstructured":"42) Fleming, C. D., Bencharit, S., Edwards, C. C., Hyatt, J. L., Tsurkan, L., Bai, F., Fraga, C., Morton, C. L., Escher, L., Williams. H., Potter, P. M. and Redinbo, M. R.: Structural insights into drug processing by human carboxylesterase 1: Tamoxifen, mevastatin, and inhibition by benzil. J. Mol. Biol.<\/i>, 352<\/b>: 165-177 (2005)","DOI":"10.1016\/j.jmb.2005.07.016"},{"key":"42","doi-asserted-by":"crossref","unstructured":"43) Bencharit, S., Morton, C. L., Howord-Williams, E. L., Danks, M. K., Potter, P. M. and Redinbo, M. R.: Structural insights into CPT-11 activation by mammalian carboxylesterases. Nat. Struct. Biol.<\/i>, 9<\/b>: 337-342 (2002).","DOI":"10.1038\/nsb790"},{"key":"43","doi-asserted-by":"crossref","unstructured":"44) Bosron, W. F. and Hurley, T. D.: Lessons from a bacterial cocaine esterase. Nat. Struct. Biol.<\/i>, 9<\/b>: 4-5 (2002).","DOI":"10.1038\/nsb0102-4"},{"key":"44","doi-asserted-by":"crossref","unstructured":"45) Sun, Z., Murry, D. J., Sanghani, S. P., Davis, W. I., Kedishvili, N. Y., Zou, Q., Hurley, T. D. and Bosron, W. F.: Methylphenidate is stereroselectively hydrolyzed by human carboxylesterase CES1A1. J. Pharmacol. Exp. Ther.<\/i>, 310<\/b>: 469-476 (2004).","DOI":"10.1124\/jpet.104.067116"},{"key":"45","doi-asserted-by":"crossref","unstructured":"46) Senter, P. D., Beam, K. S., Mixan, B. and Wahl, A. F.: Identification and activities of human carboxylesterases for the activation of CPT-11, a clinically approved anticancer drug. Bioconjugate Chem.<\/i>, 12<\/b>: 1074-1080 (2001).","DOI":"10.1021\/bc0155420"},{"key":"46","unstructured":"47) Brzezinski, M. R., Spink, B. J., Dean, R. A., Berkman, C. E., Cashman, J. R. and Bosron, W. F. Human liver carboxylesterase hCE-1: Binding specificity for cocaine, heroin, and their metabolites and analogs. Drug Metab. Dispos.<\/i>, 25<\/b>: 1089-1096 (1997)."},{"key":"47","doi-asserted-by":"crossref","unstructured":"48) Huang, H., Fleming, C. D., Nishi, K., Redinbo, M. R. and Hammock, B. D.: Stereoselective hydrolysis of pyrethroid-like fluorescent substrates by human and other mammalian liver carboxylesterases. Chem. Res. Toxicol.<\/i>, 18<\/b>: 1371-1377 (2005).","DOI":"10.1021\/tx050072+"},{"key":"48","doi-asserted-by":"crossref","unstructured":"49) Mizen, L. and Burton, G..: The use of esters as prodrugs for oral delivery of β-lactam antibiotics. Pharm. Biotechnol.<\/i>, 11<\/b>: 345-365 (1998).","DOI":"10.1007\/0-306-47384-4_15"},{"key":"49","doi-asserted-by":"crossref","unstructured":"50) Amidon, G. L., Sinko, P. J. and Fleisher, D. Estimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds. Pharm. Res.<\/i>, 5<\/b>: 651-654 (1988).","DOI":"10.1023\/A:1015927004752"},{"key":"50","doi-asserted-by":"crossref","unstructured":"51) Fagerholm, U., Johansson, M. and Lennernäs, H.: Comparison between permeability coefficients in rat and human jejunum. Pharm. Res.<\/i>, 13<\/b>: 1336-42 (1996).","DOI":"10.1023\/A:1016065715308"},{"key":"51","unstructured":"52) Pang, K. S., Yuen, V., Fayz, S., te Koppele, J. M., Mulder, G. J.: Absorption and metabolism of acetaminophen by the in situ perfused rat small intestine preparation. Drug Metab. Dispos.<\/i>, 14<\/b>: 102-111 (1986)."},{"key":"52","doi-asserted-by":"crossref","unstructured":"53) Tamura, S., Tokunaga, Y., Ibuki, R., Amidon, G. L., Sezaki, H. and Yamashita, S.: The site-specific transport and metabolism of tacrolimus in rat small intestine. J. Pharmacol. Exp. Ther.<\/i>, 306<\/b>: 310-316 (2003).","DOI":"10.1124\/jpet.103.050716"},{"key":"53","doi-asserted-by":"crossref","unstructured":"54) Zimmerman, C. L., Wen, Y. and Remmel, R. P.: First-pass disposition of (-)-6-aminocarbovir in rats: II. Inhibition of intestinal first-pass metabolism. Drug Metab. Dispos.<\/i>, 28<\/b>: 672-679 (2000).","DOI":"10.1016\/S0090-9556(24)15147-1"},{"key":"54","doi-asserted-by":"crossref","unstructured":"55) Inoue, M., Morikawa, M., Tsuboi, M. and Sugiura M.: Species difference and characterization of intestinal esterase on the hydrolyzing activity of ester-type drugs. Jpn. J. Pharmacol.<\/i>, 29<\/b>: 9-16 (1979).","DOI":"10.1254\/jjp.29.9"},{"key":"55","doi-asserted-by":"crossref","unstructured":"56) Sanghari, S. P., Davis, W. I., Dumaual, N. G., Mahrenholz, A. and Bosron, W. F.: Identification of microsomal rat liver carboxylesterases and their activity with retinyl palmitate. Eur. J. Biochem.<\/i>, 269<\/b>: 4387-4398 (2002).","DOI":"10.1046\/j.1432-1033.2002.03121.x"},{"key":"56","unstructured":"57) Prueksaritanont, T., Deluna, P., Gornam, L. M., Ma, B., Cohn, D., Pang, J., Xu, X., Leung, K. and Lin, J. H.: In vitro<\/i> and in vivo<\/i> evaluation of intestinal barriers for the zwitterion L-767,679 and its carboxyl ester prodrug L-775,318: Role of efflux and metabolism. Drug Metab. Dispos.<\/i>, 26<\/b>: 520-527 (1998)."},{"key":"57","doi-asserted-by":"crossref","unstructured":"58) Ruiz-Balaguer, N., Nacher, A., Gasabo, V. G.. and Merino Sanjuan, M.: Intestinal transport of cefuroxime axetil in rats: absorption and hyrolysis processes. Int. J. Pharm.<\/i>, 234<\/b>: 101-111 (2002).","DOI":"10.1016\/S0378-5173(01)00956-5"},{"key":"58","unstructured":"59) Okudaira, N., Tatebayashi, T., Speirs, G. C., Komiya, I and Sugiyama, Y.: A study of the intestinal absorption of an ester-type prodrug, ME3229, in rats: active efflux transport as a cause of poor bioavailability of the active drug. J. Phatmacol. Exp. Ther.<\/i>, 294<\/b>: 580-587 (2000)."},{"key":"59","doi-asserted-by":"crossref","unstructured":"60) Masaki, K., Taketani, M. and Imai, T.: First-pass hydrolysis of a propranolol ester derivative in rat small intestine. Drug Metab. Dispos.<\/i>, 34<\/b>: 398-404 (2006).","DOI":"10.1124\/dmd.105.007682"},{"key":"60","doi-asserted-by":"crossref","unstructured":"61) Yamashita, S., Tanaka, Y., Endoh, Y., Taki, Y., Sakane, T., Nadai, T. and Sezaki, H.: Analysis of drug permeation across Caco-2 monolayer: implication for predicting in vivo<\/i> drug absorption. Pharm. Res.<\/i>, 14<\/b>: 486-491 (1997).","DOI":"10.1023\/A:1012103700981"},{"key":"61","doi-asserted-by":"crossref","unstructured":"62) Artursson, P., Palm, K. and Luthman, K.: Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. Rev.<\/i>, 46<\/b>: 27-43 (2001).","DOI":"10.1016\/S0169-409X(00)00128-9"},{"key":"62","doi-asserted-by":"crossref","unstructured":"63) Lennernäs, H.: Human intestinal permeability. J. Pharm. Sci.<\/i>, 87<\/b>: 403-410 (1998).","DOI":"10.1021\/js970332a"},{"key":"63","doi-asserted-by":"crossref","unstructured":"64) Nakamura, T., Sakaeda, T., Ohmoto, N., Tamura, T., Aoyama, N., Shirakawa. T., Kamigaki, T., Nakamura, T., Kim, K. I., Kim, S. R., Kuroda, Y., Matsuo, M., Kasuga, M. and Okumura, K.: Real-time quantitative polymerase chain reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA levels in Caco-2 cell lines, human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas. Drug Metab. Dispos.<\/i>, 30<\/b>: 4-6 (2002).","DOI":"10.1124\/dmd.30.1.4"},{"key":"64","unstructured":"65) Prueksaritanont, T., Gorham, L. M., Hochman, J. H., Tran, L. O. and Vyas, K. P.: Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells. Drug Metab. Dispos.<\/i>, 24<\/b>: 634-642 (1996)."},{"key":"65","doi-asserted-by":"crossref","unstructured":"66) Yoshigae, Y., Imai, T., Horita, A., Matsukane, H. and Otagiri, M.: Species differences in stereoselective hydrolase activity in intestinal mucosa. Pharm. Res.<\/i>, 15<\/b>: 626-631 (1998).","DOI":"10.1023\/A:1011946314416"},{"key":"66","doi-asserted-by":"crossref","unstructured":"67) Li, Y-H., Ito, K., Tsuda, Y., Kohda R., Yamada, H., and Ito, T.: Mechanism of intestinal absorption of an orally active β-lactam prodrug: uptake and transport of carindacillin in Caco-2 cells. J. Pharmacol. Exp. Ther.<\/i> 290<\/b>: 958-964 (1999).","DOI":"10.1016\/S0022-3565(24)34993-6"},{"key":"67","doi-asserted-by":"crossref","unstructured":"68) Tantishaiyakul, V., Wiwattanawongsa, K., Pinsuwan, S., Kasiwong, S., Phadoongsombut, N., Kaewnopparat, S., Kaewnopparat, N. and Rojanasakul, Y.: Characterization of mefenamic acid-guauacol ester: stability and transport across Caco-2cell monolayers. Pharm. Res.<\/i>, 19<\/b>: 1013-1018 (2002).","DOI":"10.1023\/A:1016470523923"},{"key":"68","doi-asserted-by":"crossref","unstructured":"69) Imai, T., Imoto, M., Sakamoto, H. and Hashimoto, M.: Identification of esterases expressed in Caco-2 cells and effects of their hydrolyzing activity in predicting human intestinal absorption. Drug Metab. Dispos.<\/i>, 33<\/b>: 1185-1190 (2005).","DOI":"10.1124\/dmd.105.004226"},{"key":"69","unstructured":"70) Khanna, R., Morton, C. L., Danks, M. K. and Potter, P. M.: Proficient metabolism of irinotecan by a human intestinal carboxylesterase. Cancer Res.<\/i>, 60<\/b>: 4725-4728 (2000)."},{"key":"70","doi-asserted-by":"crossref","unstructured":"71) Schwer, H., Langmann, T., Daig, R., Becker, A., Aslanidis, C. and Schmitz, G.: Molecular cloning and characterization of a novel putative carboxylesterase, present in human intestine and liver. Biochem. Biophys. Res. Commun.<\/i>, 233<\/b>: 117-120 (1997).","DOI":"10.1006\/bbrc.1997.6413"},{"key":"71","unstructured":"72) Sanghani, S. P., Quinney, S. K., Fredenburg, T. B., Sun, Z., Davis, W. I., Murry, D. J., Cummings, O. W., Seitz, D. E. and Bosron, W. F. Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysis. Clin. Cancer Res.<\/i>, 9<\/b>: 4983-4991 (2003)."},{"key":"72","doi-asserted-by":"crossref","unstructured":"73) Xie, M., Yang, D., Liu, L., Xue, B. and Yan, B.: Human and rodent carboxylesterases: immunorelatedness, overlapping substrate specificity, differential sensitivity to serine enzyme inhibitors, and tumor-related expression. Drug Metab. Dispos.<\/i>, 30<\/b>: 541-547 (2002).","DOI":"10.1124\/dmd.30.5.541"},{"key":"73","doi-asserted-by":"crossref","unstructured":"74) Pavillard, V., Agostini, C., Richard, S., Charasson, V., Montaudon, D. and Robert, D. J.: Determinants of the cytotoxicity of irinotecan in two human colorectal tumor cell lines. Cancer Chemother. Pharmacol.<\/i>, 49<\/b>: 329-335 (2002).","DOI":"10.1007\/s00280-001-0416-0"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715306650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715306650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T19:48:49Z","timestamp":1736452129000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436715306650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006]]}},"alternative-id":["S1347436715306650"],"URL":"https:\/\/doi.org\/10.2133\/dmpk.21.173","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2006]]}}}